Introduction we identified as a target for AMV v-myb. Expression of GBX2 in E26-transformed cells induces morphological The c-myb gene encodes a transcription factor that and functional monocytic features and allows them to regulates the growth and differentiation of immature hegrow in the absence of exogenously added growth facmatopoietic cells and that is required for mammalian tor, thus reflecting the AMV phenotype. The protooncohematopoiesis (Mucenski et al., 1991; Graf, 1992) . Exgene c-myb requires an activated system of protein pression of c-myb is highest in proliferating, immature kinases to induce GBX2. The latter requirement is uncells, and it is overexpressed in a variety of leukemias necessary in AMV-transformed cells: the mutations in and solid tumors (Wolff, 1996) . However, ectopic expresthe v-Myb DNA binding domain override the need for sion of c-myb is not sufficient to induce tumors in cooperating protein kinases, allowing AMV v-Myb to transgenic animals (Furuta et al., 1993) , suggesting that constitutively activate GBX2 and simultanously to abroactivating mutations are required to reveal its oncogenic gate collaboration with CCAAT enhancer binding proactivity (Graf, 1992; Lipsick, 1996) . Two different, indeteins (C/EBP), which are involved in granulocytic differpendently isolated avian leukemia viruses have transentiation (Mü ller et al., 1995; Zhang et al., 1997) . Our duced v-myb oncogenes that encode mutated, actiresults identify GBX2 as an important downstream tarvated Myb proteins and that induce acute leukemias in get of Myb and shed light on the mechanisms of growth animals (Graf and Stehelin, 1982) . Both viruses transcontrol and lineage commitment in the hematopoietic form hematopoietic precursor cells in tissue culture, alsystem and the activation of the myb oncogene. though each displays a unique transformation specificity within the hematopoietic system. Results The E26 virus encodes a complex chimeric protein in which v-Myb is fused to a second oncoprotein, v-Ets.
The Homeodomain Protein GBX2 Binds E26 causes a precursor type leukemia with prevailthe cMGF Promoter ing erythroleukemic features and transforms multipotent One of the most striking features distinguishing AMVand myeloid progenitors in vitro . Deleand E26-transformed myeloid cells is that only the fortion of v-ets renders E26 nonleukemogenic in animals.
mer exhibit autocrine growth capacity, caused by their However, the myeloid leukemogenicity and transforming ability to secrete small quantities of cMGF (Dini et al., 1995, and A. L., unpublished data) . Since the cMGF promoter lacks binding sites for the Myb protein but 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed.
nevertheless was activated by AMV but not by E26 the Ϫ95cMGF promoter-luciferase construct or an A site deletion construct (Ϫ46cMGF) after transfection into QT6 fibroblasts along
We used an electrophoretic mobility shift assay to with or without a GBX2 expression vector as indicated. Bars repreidentify differences in cMGF promoter-binding proteins sent means of duplicates.
in nuclear extracts from AMV-and E26-transformed myeloblasts. As shown in Figure 1B , an oligonucleotide probe, which spanned the A site regulatory element cenisolated one positive clone that contained a 1.6 kb cDNA tered around position Ϫ86 of the cMGF promoter (Sterinsert. Sequence analysis and data base search reneck et al., 1992b), shifted a novel, AMV-specific comvealed an open reading frame able to encode a homeoplex (lane 1) in addition to the previously identified AP1 domain protein closely related to GBX2. The highest complex present in both cell types (compare lanes 1 protein sequence conservation is located in the homeoand 8). Competition experiments using canonical AP1 domain, which is identical in the chicken and mammalian oligo (lane 2), the partially overlapping B site (lane 2), or proteins (data not shown). DS-260, an upstream protein binding site of the cMGF The GBX2 coding region was expressed as a Glutathipromoter related to the A site (lane 5), suggested that one-S-Transferase (GST) fusion protein in E. coli. The a novel factor expressed in AMV-myeloblasts binds both recombinant protein bound DNA with a specificity that to the A site and to a distal site at position Ϫ260 (data was indistinguishable from that of native complex II not shown) in the cMGF promoter. Finally, the use of (data not shown). GST-GBX2 was used as an antigen mutated oligonucleotides revealed that an ATTA core to prepare both rabbit polyclonal antisera and mouse sequence was essential for formation of the complex II monoclonal antibodies, and these antibodies revealed but not for binding by AP1.
that the GBX2 protein expressed in transiently transfected Cos-7 cells was localized exclusively in nuclei GBX2 Regulates the cMGF Gene (data not shown). To analyze GBX2 protein expression To identify the factor(s) that form complex II, we used in more detail, we subjected nuclear extracts from AMVa multimerized DS-260 oligonucleotide to screen a gt11 transformed cells to Western blotting and to SouthcDNA expression library derived from AMV-transformed BM2 cells. We screened a total of 1.6 ϫ 10 5 phages and Western analyses (Figure 2A ). Extracts from transfected Cos-7 cells expressing the GBX2 cDNA and Reticuloendotheliosis virus (REV)-transformed preB/T cells served as positive and negative controls, respectively. The GBX2 cDNA encoded proteins of three different sizes (lane 3), migrating at approximately 45, 43, and 38 kDa (p45, p43, and p38, respectively), all of which were also detected in Western blots of AMV-transformed myeloblasts (lane 2). The same proteins were also detected in South-Western blot assays, using a radiolabled oligonucleotide probe derived from the cMGF promoter A site as a probe (lanes 5 and 9), suggesting that all three GBX2 forms are expressed in vivo, and all are able to bind specifically to DNA. To confirm that GBX2 can regulate the cMGF promoter, we examined whether ectopically expressed GBX2 can induce reporter expression. As shown in Figure 2B , GBX2 activated reporter expression from the cMGF minimal promoter when the GBX2 binding site was present, but not when it was deleted. Thus, GBX2 protein binds specifically to DNA and activates transcription from the cMGF promoter.
GBX2 Expression in Hematopoietic Cells
We used a semiquantitative RT-PCR procedure to analyze the expression of both GBX2 and the closely related GBX1 (also known as cHox7) genes in various chicken tissues as shown in Figure 3A . As expected, we found that both genes were expressed in brain, consistent with reports of murine GBX gene expression (Murtha et al., Figure 3 . Expression Analysis of Chicken and Human GBX Genes 1991; Bulfone et al., 1993) . In addition, we found GBX1
(A) RT-PCR assay of various tissues derived from 13-day-old chicken. RNA was extracted, reverse transcribed, and amplified but not GBX2 to be expressed in skeletal muscle. In using specific primers for GBX1, GBX2, and GAPDH, respectively.
contrast, GBX2 but not GBX1 was detected in all he-PCR fragments were labeled by inclusion of 0. the expression of both GBX genes in various cell lines.
(B) Northern analysis of polyA-enriched RNA from chicken cell lines as indicated using the 3Ј untranslated GBX2 cDNA as a probe. Figure 3B shows expression of GBX2 mRNA in blast-like hematopoietic expression of GBX2 occurs in higher vertebrates, we examined various human hematopoietic remains inactive on estrogen receptor targets. Activacell lines ( Figure 3C ). The progenitor cell line K562 and tion of GBX2 as well as mim-1 occurred with both estrothe B-lymphocyte SKW64 line both expressed GBX2, gen and OHT, largely excluding effects that might be while several others (Jurkat, Raji, Blin; data not shown) caused by endogenous steroid hormone receptors or were negative or showed only negligible expression.
the ER moiety of the Myb-chimera. Furthermore, activaTaken together, these data suggest that GBX2 is extion occured even when protein synthesis was blocked pressed in several hematopoietic lineages in vertewith cycloheximide (CHX) prior to hormone treatment brates.
( Figure 4B ). In contrast, no GBX2 or mim-1 gene activation was observed in CHX-treated 10.4HD11 cells in the GBX2 Is a myb Target Gene absence of hormone or in estrogen/OHT-treated parenTo determine whether GBX2 is a myb target gene, we tal cells ( Figure 4C ). Taken together, these data suggest took advantage of a macrophage cell line that harthat GBX2 is a direct target gene of the v-Myb protein. bors a chimeric estrogen receptor v-Myb fusion protein
The v-Myb protein encoded by AMV contains numer-(v-MybER; 10.4HD11 cells) and that can be conditionally ous point mutations that contribute to leukemogenicity activated by estradiol (Burk and Klempnauer, 1991) . As and cMGF-independent growth and that affect the shown in Figure 4 , estrogen treatment of 10.4HD11 cells transformed cell phenotype (Introna et al., 1989 ; Dini et rapidly induced expression of both GBX2 and mim- 1, al., 1995) . We therefore examined the structural requirethe first myb target gene identified . ments related to the ability of v-Myb to activate GBX2 To further explore the specificity of GBX2 activation by and mim-1 by transfecting a series of Myb mutants into v-mybER, cells were treated with estrogen or hydroxyta-HD11 macrophages that express both C/EBP␣ and moxifen (OHT; Figure 4B ), a synthetic estradiol antagonist that activates estrogen receptor fusion proteins but C/EBP␤ (A. Leutz, unpublished data). As shown in Figure 5, only AMV v-myb induced GBX2 expression, while all other Myb proteins with intact transactivation domains induced mim-1 but not GBX2. These findings agree with published results showing that E26 v-myb but not AMV v-myb activates mim-1 (Introna et al., 1989) . These results suggest that AMV v-myb accumulated gain-as well as loss-of-function mutations, which led simultaneously to constitutive activation of GBX2 coupled with the loss to cooperate with C/EBP. To study this possibility further, we tested reciprocal exchange mutants between c-myb and AMV v-myb. As shown in Figure 5B and summarized in Figure 5C , the ability to induce GBX2 and the inability to activate mim-1 are both dependent on the AMV-specific point mutations in the v-Myb DNA binding domain and are independent of changes in the N-or C-terminal regions of Myb.
c-Myb Requires an Activated Signaling Pathway to Induce GBX2
Failure of c-myb to activate GBX2 could reflect a change in target gene specificity of the AMV-myb version or a transient physiological condition that was not provided in our experiments shown in Figure 5 . The observation that c-myb expressing v-erbB-transformed erythro- EGF receptor tyrosine kinase (Metz et al., 1991) . polyoma middle T (POMT) or EJ-ras along with c-myb into HD11 cells or treated cells with phorbol ester to activate protein kinase C (PKC). As shown in Figure 6B , that GBX2 enhanced the transformation potential of the E26 oncogene probably by causing at least partial independence from exogenously added cMGF. Next, we characterized the phenotype of E26GBX2-transformed cells in more detail. We observed that E26GBX2-transformed colonies were generally more diffuse in comparison to the compact E26 myeloblast colonies ( Figure 7A ). Approximately 30%-50% of the E26GBX2-transformed colonies were without a sharp boundary, indicative of migratory monocytic cells, whereas Ͼ95% of the E26 colonies were extremely compact. When isolated and grown in liquid medium, E26GBX2-transformed cells were significantly larger than E26 myeloblasts (442 fl Ϯ 75 fl versus 305 fl Ϯ 19 fl; data from 12 clones each). Many E26GBX2-transformed cells grew as semiadherent cells, reminiscent of the AMV monoblast-like cells, while E26-transformed cells were Myl51-2 (data not shown), but E26GBX2-and AMVtransformed cells expressed 5-10 fold more MHCII antigen on their surface (Ewert et al., 1984) . These data GBX2 was activated when c-myb was cotransfected
show that E26GBX2 cells more closely resemble AMVtogether with POMT or EJ-ras but not by POMT, EJ-ras, transformed monoblasts than E26-transformed myeloor c-myb alone or in conjunction with an activated PKC blasts. pathway. In contrast, activation of mim-1 also required When individual colonies of transformed cells obc-myb but occurred independently of cotransfected tained in the presence of cMGF were reseeded in liquid EJ-ras, POMT, or phorbol ester treatment through colmedium either with or without cMGF, 11 out of 12 laboration between Myb and C/EBP, which is abun-E26GBX2 clones regrew in the absence of cMGF, while dantly expressed in HD11 cells  none of the E26 clones examined were able to grow in Ness et al., 1993) . the absence of added cMGF (data not shown). This We conclude that c-Myb collaborates with, or is a suggests that the E26-transformed cells remained comtarget of, a signaling pathway originating at the cell pletely cMGF-dependent, but that the E26GBX2-transsurface to induce GBX2. The mutations in the DBD of formed cells no longer required exogenous cytokine adthe leukemic AMV v-Myb render it independent on such dition for their growth or survival. To determine whether signals and, as a consequence, lead to the constitutive factor-independent growth was due to autocrine growth activation of GBX2. Simultaneously, the mutations in the stimulation, we compared growth of both cell types un-AMV v-Myb DBD abrogate the collaboration between der different conditions. First, pools of approximately 50 Myb and C/EBP, a hallmark of the granulocytic phenocolonies from E26-or E26GBX2-infected bone marrow type (Mü ller et al., 1995; Zhang et al., 1997) .
cultures produced in the presence of cMGF were expanded in liquid medium plus cMGF to eliminate selecEctopic Expression of GBX2 in Hematopietic tion for growth factor independence. The resulting cell Precursor Cells Alters Their Phenotype populations were then reseeded, and their growth was Having shown that GBX2 is a target gene of AMV v-Myb, monitored either in the presence or absence of cMGF a major question was whether ectopic expression of ( Figure 8A ). The E26GBX2-transformed cells grew about GBX2 would alter the phenotype and cytokine depentwice as fast in the presence of exogenous cMGF as in dence of myelomonocytic precursor cells. We therefore its absence. In contrast, E26-transformed control cells constructed a recombinant retrovirus that encodes were unable to proliferate at all in the absence of GBX2 in combination with the transforming v-myb-ets cMGF. As shown in Figure 8B , medium conditioned by gene of the E26 virus ( Figure 7A ). Primary chicken bone E26GBX2-but not by E26-transformed cells contained marrow cells were infected with either the recombinant a growth-promoting activity. Furthermore, growth of E26GBX2 virus, wild-type E26 or AMV viruses, or helper E26GBX2-transformed cells was inhibited by a cMGFvirus, and infected cells were seeded into semisolid tisspecific antiserum but not by an irrelevant serum (Figure sue culture medium either in the presence or absence 8C). Addition of excess, recombinant cMGF restored of cMGF. Table 1 shows that transformed colonies decell growth, indicating that inhibition was not mediated veloped with both E26GBX2 and AMV but not with E26 by antiserum toxicity (Adkins et al., 1984) (data not shown). We conclude that E26GBX2-transformed cells virus in the absence of added cMGF. These results show secrete cMGF (or an immunologically related cytokine), of both growth ( Figure 8C ) and conditioned medium (data not shown) of E26GBX2-transformed cells. which stimulates the cells to grow through an autocrine mechanism. However, we cannot currently exclude exTo rule out the possibility that the observed differences between E26GBX2-and E26-transformed cells pression of additional, yet unknown cytokines as indicated by partial neutralization by the cMGF antiserum resulted from outgrowth of different target cells, we examined whether established E26 myeloblasts would change their phenotype after expression of GBX2. E26 myeloblasts superinfected with a GBX2-expressing kine cMGF in an autocrine fashion. We cloned the chicken homeobox gene GBX2 and identified it as a nuclear factor expressed in AMV monocytes that binds to and activates transcription from the cMGF promoter. Furthermore, we demonstrated that GBX2 is a myb target gene and showed that ectopic expression of GBX2 in myeloblasts mediates monocytic differentiation and growth factor independence, reflecting distinct features of the AMV v-myb oncogene. The induction of GBX2 by c-Myb requires an activated tyrosine kinase pathway originating at the cell surface. The dependence of Myb on signal transduction during GBX2 activation is abrogated by mutations present in the AMV-Myb DBD. The same mutations abrogate the collaboration between Myb and C/EBP, which previously was identified as a bipartite switch controlling the expression of several differentiation-specific genes. Our data suggest that gain-and loss-of-function mutations in the DBD of Myb are simultaneously required to convert it into a leukemia gene and to determine the transformed phenotype.
Induction of the GBX2 Gene Requires Myb in Conjunction with an Activated Signaling Pathway
The c-myb protooncogene is required for and controls adult hematopoiesis (Mucenski et al., 1991) . When Under normal conditions, activation of GBX2 through Myb occurs through signals emanating at the cell surface. It will therefore be interesting to determine exactly speculate that hematopoietic transcription factors such as AML1, ets-1,-2, or PU.1 might be involved in such which hematopoietic surface receptors transmit signals to induce GBX2 expression and how signaling pathways interactions, although preliminary experiments do not support this speculation. regulate the transcriptional activity of Myb through its DBD. Currently, our results suggest that Ras-MAPkinase pathways are involved although the mechanism Myb and the Regulation of a Homeobox Gene Of particular importance is the finding that activated remains to be elucidated.
None of the amino acids mutated in the AMV DBD signaling pathways in conjunction with Myb induce the expression of a nonclustered homeobox gene. Since either in the wild-type or the mutant configuration can serve as phosphorylation sites. Therefore, it seems likely GBX2 is involved in the regulation of other genes exemplified by the cMGF cytokine, our data also suggest that that the activity of Myb is subject to regulation through allosteric modifications or through interacting proteins, Myb acts as a master regulator in hematopoiesis by controlling the expression of transcription factors on a which may or may not require adjacent cis-regulatory binding sites. Interestingly, the respective AMV point lower hierarchical level. In the hematopoietic system, a number of homeobox mutations are positioned on the surface of the Myb DBD that faces away from the DNA toward the solvent (Ogata genes might participate in the control of cell lineage commitment, proliferation, differentiation, and leukemia et al., 1994). In the wild-type version, those positions are occupied by hydrophobic amino acids that might development (Kehrl, 1994; Shivdasani and Orkin, 1996) . Certain members of the HOXB cluster are expressed form a contiguous hydrophobic furrow. Such a hydrophobic surface structure is interrupted in AMV-myb. It in primitive hematopoietic cells, and overexpression of HOXB4 causes a selective expansion of this comparttherefore seems plausible that the DBD of Myb could serve as an interaction surface for one or several accesment (Sauvageau et al., 1995) . Recently, three homeobox genes, MEIS1, HOXA7, and HOXA9 were found upsory protein(s) and that the AMV-myb mutations interfere with some of those interactions. It is tempting to regulated in murine BXH2 leukemia induced by retroviral insertion mutagenesis. Importantly, rearrangement and by regulating different sets of genes in response to extracellular signals and/or through interactions with diftranslocation of the HOXA9 gene also occurs in human acute myeloid leukemia, establishing its role in hematoferent sets of transcription factors. poietic transformation (Nakamura et al., 1996a (Nakamura et al., , 1996b . Several other nonclustered homeodomain genes are Experimental Procedures also implicated in normal and dysregulated hematoRetroviral Constructs and Pseudotyping poiesis, such as the TCL-3 gene (HOX11), which is reThe GBX2 cDNA was inserted into an E26 IRES retrovirus construct arranged and up-regulated in rare cases of T-cell acute and into RCAS-A (Hughes et al., 1987) . Chicken embryo fibroblasts leukemia (Hatano et al., 1991; Kennedy et al., 1991) , or were transfected with recombinant and helper virus plasmid (RAV-2) the MEIS1-related PBX1 gene, which is fused to the E2A and selected in G418 at 0.8 mg/ml as previously described (Metz transcription factor in pre-B cell lymphoblastic leukeet al., 1991). RCAS-A-transfected fibroblasts were grown without selection. Transgene expression was controlled by Western blotting mias characterized by a t(1;19) rearrangement (Kamps after 10 days, and culture supernatants were stored at Ϫ70ЊC as a et al., 1990; Kamps and Baltimore, 1993) . Thus, the exsource of virus. pression of individual genes or sets of homeobox genes in the hematopoietic system are clearly linked to proliferChicken Tissues, Cell Lines, and Tissue Culture ation and differentiation control.
Tissue was obtained from 13-day-old White Leghorn SPAFAS It is noteworthy to mention that hematopoietic GBX2 chicken. The HD3 cell line expressing v-erbB and the HD11 cell line expression is not restricted to the monocytic lineage expressing v-myc have been described (Beug et al., 1979 (Beug et al., , 1982 .
and was also not observed in more mature, v-myc trans-BM-2 is an AMV-transformed monoblast cell line (Moscovici and Gazzolo, 1982) . MH2-transformed cells express v-myc and v-mil formed macrophages. It therefore appears that the (Coll et al., 1983) . HD57 cells are E26-transformed progenitors exdifferentiation activity and the expression of GBX2 is pressing the v-myb-ets oncogene . The cell lines dynamically regulated, as it is the case with many other MSB-1 and RPL-12 are T-and B-lymphoblasts, respectively, and homeodomain proteins. Interestingly, both erythroid were isolated from bird tumors (Beug et al., 1981) . REV-NPB4 is a chicken HD3 cells and progenitor like human K562 cells REV-transformed pre-B/pre-T-cell line expressing the v-rel oncoexpress high levels of c-myb, activated tyrosine kinase gene (Beug et al., 1981) . CEF38 is a fibroblast cell line (Kaaden, 1977) . All cells were grown in Dulbecco's modified Eagle medium oncogenes (v-erbB and bcr-abl, respectively), and GBX2. ing GBX2 in distinct hematopoietic lineages, for exabsence of recombinant cMGF (Leutz et al., 1989) . After 8-10 days, ample.
transformed colonies were isolated and expanded in liquid culture. Superinfection (1 ϫ 10 5 cells) with RCAS-A or RCASAGBX2 virus was performed 4 days later.
Is Myb Involved in Hematopoietic Lineage Commitment and Differentiation? Cytokine Assays
Constitutive activation of GBX2 depends on the point Supernatants of cells were harvested, steril filtered, and titrated on mutations in the AMV v-Myb DBD, which determine the E26 myeloblasts . Briefly, E26 test cells were washed twice with DMEM to remove cMGF. Cells were then seeded leukemogenicity and the phenotype of transformed cells into titrated supernatants in 96-well plates at 2 ϫ 10 4 cells in 50 l (Introna et al., 1989) . In this regard, it is interesting to of medium. After 2 days, viable cells were counted. Autocrine growth compare our results with those obtained by others in was determined by adding anti-cMGF or preimmune serum at a two extensive surveys on the structure/function relationconcentration of 0.5% to the culture medium.
ship of the v-Myb DBD (Introna et al., 1989; Dini et al., 1995) . These studies showed that the monoblast phenoPhagocytosis, Cytochemical, and type and the growth factor production segregate with
Immunocytochemical Methods
the AMV v-myb DBD configuration. Here we showed Cells were fed with bacteria or FITC-labeled latex beads at a 1:100 ratio for 1-2 hr as described earlier (Beug et al., 1979) . Cytocentrifuge that the same region determines the collaboration with preparations of cells were stained with a Giemsa-like stain (Diff-C/EBP proteins and the activation of the GBX2 gene. The GBX2 cDNA was sequenced using dGTP, dITP, and 7-deaza-GBX2/5Ј 5Ј-TCCAAGGCGGGGGAACCGTCG-3Ј dGTP reactions in parallel. Poly(A)ϩ RNA was isolated using GBX2/3Ј 5Ј-TGCTGGTGCTGACTCCTGAT-3Ј Dynabeads Oligo(dT)25 (Dynal). RNA was separated on 1% agarose-GBX1/5Ј 5Ј-AACCGCTCGGGAGAGCCCGTC-3Ј formaldehyde gels, transferred to nylon membranes, UV cross-GBX1/3Ј 5Ј-TGCTGGTGCTGGCTGCGCAC-3Ј linked, and baked at 80ЊC for 2 hr. The GBX2-specific DNA probe GAPDH/5Ј 5Ј-CCATGACAACTTTGGCATTG-3Ј was isolated from phage 30.1 insert following HincII/ EcoRI diges-GAPDH/3Ј 5Ј-TCCCCACAGCCTTAGCAG-3Ј tion. The crossreacting GBX homeobox probe was a SstII and HincII hGBX2/5Ј 5Ј-AAGTACCTCTCCTTGACCGAG-3Ј fragment. Restriction fragments used as probes for GAPDH, mim-1, hGBX2/3Ј 5Ј-GCTGACTTCTGATAGCGAACC-3Ј and cMGF have been described (Leutz et al., 1989; . Probes were labeled by random priming and hybridized to Expression Screening and Isolation of GBX2 membranes in QuickHyb (Stratagene) at 68ЊC for 2 hr. Filters were The chicken BM-2 cell cDNA library constructed in the expression washed twice in 0.2 ϫ SSC/0.1% SDS at 65ЊC for 15 min and exvector gt11 was obtained from A. Sippel (University of Freiburg).
posed at Ϫ70ЊC. For rehybridization, filters were stripped for 10 min The library had an average insert size of approximately 1.5 kb. For at 95ЊC in 0.05 ϫ SSC/0.1% SDS. lytic growth of bacteriophage l, the standard host strain Y1090 was used. Bacteriophage infection, plating, and screening were carried Western and South-Western Analysis out according to published procedures (Singh et al., 1988; Vinson Protein extracts were prepared by a mini nuclear extract procedure et al., 1988) . In brief, bacteriophage fusion protein expression was (Schreiber et al., 1989) . For detection of GBX2 in hematopoietic induced after 5 hr at 42ЊC by overlaying with IPTG-impregnated cells, cells were lysed by Dounce homogenization. Proteins were nitrocellulose filters and overnight growth at 37ЊC. Plates were subjected to reducing 12.5% SDS-PAGE and electrophoretically chilled, filters were lifted and immersed in HEPES binding buffer transferred onto PVDF membrane. Membranes were blocked with (25 mM HEPES [pH 7.9], 25 mM NaCl, 5 mM MgCl2, 0.5 mM DTT) 5% nonfat dry milk in TBST (150 mM NaCl, 50 mM Tris-HCl [pH 7.4], supplemented with 8 M urea. After a renaturation step, filters were 0.02% v/v Tween-20) for 2 hr and incubated overnight at 4ЊC with incubated for 2 hr in BLOTTO. Multimerized oligonucleotide probes monoclonal antibodies at a concentration of 5 mg/ml in blocking were labeled by nick translation and incubated with filters for 4 hr solution. Blots were washed three times with TBST, one time in highin binding buffer. After four washes (a total of 30 min) in binding salt buffer (0.5 M NaCl, in TBST), and incubated with a horseradish buffer containing 0.1% sodium pyrophosphate, filters were exposed peroxidase-coupled second antibody (goat anti-mouse) for 2 hr. at Ϫ70ЊC with intensifying screens. Phages were plaque purified Following three washes with TBST, immunoreactivity was monitored and EcoRI inserts subcloned into Bluescript (Stratagene). A chicken using a chemoluminescence system (ECL, Amersham). Southwest-GBX1 genomic clone was derived from a genomic phage library ern analysis was performed as described (Singh et al., 1988) . Multiscreened with a GBX2 homeobox probe. Sequence analysis conmerized oligonucleotide probes were labeled by nick translation. firmed the close relationship of our GBX1 isolate with the published Unspecific competitor poly(dI-dC) was added to a final concentrapartial chox7 sequence (Fainsod and Gruenbaum, 1989) . tion of 5 g/ml in HEPES binding buffer.
Expression Constructs
The insert of phage clone 30.1 was subcloned into the bacterial Electrophoretic Mobility Shift Assay vector pGEX-1, and expression of glutathione-S-transferase/GBX2 Double-stranded oligonuleotides were labeled with [␣-32 P] dCTP fusion protein (Gst-GBX2) was induced by IPTG. Bacteria were har-(3000 mCi/mmol, Amersham) by fill-in reaction using Klenow DNA vested and proteins were extracted as described (Smith and Johnpolymerase and purified by polyacrylamide gel electrophoresis. Nuson, 1988) . For eukaryotic expression, the phage 30.1 insert was clear extracts (0.5-1 l) were incubated in a final volume of 10 l subcloned into the pCDM8 expression vector.
with labeled fragment (0.25-1 ng) for 30 min on ice. For competition analysis, a 50-fold molar excess of cold oligonucleotides was used.
RT-PCR
The reaction mixture was separated on 5% polyacrylamide/bisacryTotal RNA was prepared from chicken tissue (Chomczynski and lamide (29:1, w/w) gels at 25 mA at room temperature using 0.5ϫ Sacchi, 1987) . Total RNA (5 g) was reverse transcribed using Super-TBE as electophoretic running buffer. script RNAseH (GIBCO/BRL). Of the resulting cDNA, 5% served as template for the PCR reactions in 50 l of 1ϫ Taq polymerase buffer
